# Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

> **NCT01735227** · PHASE4 · UNKNOWN · sponsor: **Yaling Han** · enrollment: 620 (estimated)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** omeprazole
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT01735227
- **Lead sponsor:** Yaling Han
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 620 (ESTIMATED)
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735227, "Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01735227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*